Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Efficacy of stem cell boost (SCB) for chimeric antigen receptor-T cell therapy (CAR-T)-related hematologic toxicity in patients with relapsed/refractory multiple myeloma (RRMM)-real world experience from the US multiple myeloma immunotherapy consortium.

Blood cancer journal·2026
Same author

Re: Durvalumab in combination with BCG for BCG-naive, high risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial.

European urology·2026
Same author

Belantamab mafodotin, carfilzomib, lenalidomide, and dexamethasone for relapsed or refractory multiple myeloma.

Blood advances·2026
Same author

Racial and socioeconomic disparities from time of diagnosis to treatment for small renal masses.

BJUI compass·2026
Same author

Twelve-Month Results From the CISTO Study Comparing Radical Cystectomy Versus Bladder-Sparing Therapy for Recurrent High-Grade Non-Muscle-Invasive Bladder Cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2025
Same author

Beyond the Scalpel: Unpacking the Difference Between Good Surgeons and Good Leaders.

Urology·2025
Same journal

Ipsilateral sampling maintains clinically significant cancer detection and reduces overdiagnosis in PI-RADS 4-5 lesions.

Urologic oncology·2026
Same journal

Testis-sparing surgery for small testicular masses: Functional and oncological outcomes.

Urologic oncology·2026
Same journal

Subcapsular versus total orchiectomy in advanced prostate cancer: A systematic review and meta-analysis of clinical and patient-reported outcomes.

Urologic oncology·2026
Same journal

Featured SUO Fellow: Soum Lokeshwar, MD MBA.

Urologic oncology·2026
Same journal

Automating standardization of prostate cancer biopsy and histopathology reports with privacy-preserving local large language models.

Urologic oncology·2026
Same journal

Geospatial correlation of industrial plastics emissions with bladder and kidney cancer burden in Ohio.

Urologic oncology·2026
查看所有相关文章

相关实验视频

Updated: Jan 11, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

8.9K

协议驱动的同一天释放机器人激进前列腺切除术.

Emily H Roebuck1, Lila G McGrath1, Myra Robinson2

  • 1Wake Forest School of Medicine, Winston Salem, NC.

Urologic oncology
|November 12, 2025
PubMed
概括
此摘要是机器生成的。

在机器人辅助腹腔镜前列腺切除术 (RALP) 后,当天排泄 (SDD) 是安全有效的. 一个标准化的SDD协议改善了护理的一致性,而不会增加诸如再入院或并发症等不良事件.

关键词:
评估,患者的结果.术后并发症 术后并发症准备放管计划 计划放管计划在医院重新入院.进行前列腺切除术.

更多相关视频

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

793
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.4K

相关实验视频

Last Updated: Jan 11, 2026

Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

8.9K
Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

793
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
12:45

Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer

Published on: February 12, 2022

6.4K

科学领域:

  • 泌尿器科 泌尿器科 泌尿器科 泌尿器科
  • 手术瘤学手术瘤学
  • 医疗保健服务研究 医疗服务研究

背景情况:

  • 机器人辅助腹腔镜前列腺切除术 (RALP) 通常需要24-48小时的住院时间.
  • 为了优化患者护理和资源利用,正在探索RALP后同日出院 (SDD) 的标准化协议.

研究的目的:

  • 对接受RALP的患者实施标准化当日出院 (SDD) 协议的安全性和有效性进行评估.
  • 为了比较SDD的结果与RALP后的传统住院治疗 (IP-RALP).

主要方法:

  • 对220名RALP患者进行了回顾性队列研究.
  • 实施了标准化的SDD协议,扩大了资格,并正式化了外科手术期间的管理.
  • 在同一天出院 (SDD) 和住院 (IP-RALP) 组中分析了患者,并使用适当的统计测试比较了结果.

主要成果:

  • 在149名患者中,132名 (88.6%) 接受了SDD协议,在同一天成功出院.
  • 在SDD和IP-RALP组之间,在急诊室访问,24小时再入院或整体并发症率方面没有发现显著差异.
  • 虽然30天的再接收在SDD组略高 (9.1%对4.6%),但这在统计学上并不显著. 该协议改善了POD1接触率和出院药物管理的一致性.

结论:

  • 随着RALP后的同日释放 (SDD) 是一个安全的策略,与不良事件的风险增加无关.
  • 正式化SDD协议可以提高排放过程和外科手术期间管理的一致性.
  • 建议对手术前风险分层进行进一步的研究,以定制SDD护理计划.